Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 42, 2015, Pages 13057-13062

  Chen, Jung Tsu ^a,b,c,d   Chen, Chein Hung ^b   Ku, Ko Li ^a   Hsiao, Michael ^b   Chiang, Chun Pin ^a,c,d   Hsu, Tsui Ling ^b   Chen, Min Huey ^a,c,d   Wong, Chi Huey ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CD276; Fucose; Glycan sequencing; Proliferation; Terminal galactose

Indexed keywords

GALACTOSE; GLYCAN; GLYCOPROTEIN; INTERCELLULAR ADHESION MOLECULE 3; LANGERIN; TUMOR MARKER; B7 ANTIGEN; CD276 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CELL; CANCER PATIENT; CANCER STAGING; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; FUCOSYLATION; GENE SILENCING; GLYCOSYLATION; IMMUNE RESPONSE; MOUSE; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIALYLATION; SURVIVAL RATE; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; HUMAN; IMMUNOLOGY; METABOLISM; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

B7 ANTIGENS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; GLYCOSYLATION; HUMANS; MOUTH NEOPLASMS;

EID: 84947484053     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1516991112     Document Type: Article

References (45)

1. Torre LA, et al. (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87-108.
2. Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R (2013) Epidemiology of oral cancer in Asia in the past decade-an update (2000-2012). Asian Pac J Cancer Prev 14(10):5567-5577.
3. Chen YK, Huang HC, Lin LM, Lin CC (1999) Primary oral squamous cell carcinoma: An analysis of 703 cases in southern Taiwan. Oral Oncol 35(2):173-179.
4. Brennan M, et al. (2007) Management of oral epithelial dysplasia: A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(Suppl:S19):e11-e12.
5. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371(9625):1695-1709.
6. Jemal A, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71-96.
7. Argiris A, Li Y, Forastiere A (2004) Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck. Cancer 101(10): 2222-2229.
8. Dube DH, Bertozzi CR (2005) Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat Rev Drug Discov 4(6):477-488.
9. Dennis JW, Granovsky M, Warren CE (1999) Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1473(1):21-34.
10. Manoharan S, Padmanabhan M, Kolanjiappan K, Ramachandran CR, Suresh K (2004) Analysis of glycoconjugates in patients with oral squamous cell carcinoma. Clin Chim Acta 339(1-2):91-96.
11. Jamal B, et al. (2012) Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer. Oral Oncol 48(6): 523-529.
12. Liu G, et al. (2013) N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration. J Biol Chem 288(28):20217-20227.
13. Nita-Lazar M, et al. (2009) Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer. Cancer Res 69(14): 5673-5680.
14. Lin WL, Lin YS, Shi GY, Chang CF, Wu HL (2015) Lewisy promotes migration of oral cancer cells by glycosylation of epidermal growth factor receptor. PLoS One 10(3): e0120162.
15. Chapoval AI, et al. (2001) B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2(3):269-274.
16. Leitner J, et al. (2009) B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction. Eur J Immunol 39(7):1754-1764.
17. Steinberger P, et al. (2004) Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol 172(4):2352-2359.
18. Loos M, Hedderich DM, Friess H, Kleeff J (2010) B7-h3 and its role in antitumor immunity. Clin Dev Immunol 2010:683875.
19. Roth TJ, et al. (2007) B7-H3 ligand expression by prostate cancer: A novel marker of prognosis and potential target for therapy. Cancer Res 67(16):7893-7900.
20. Zang X, et al. (2007) B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci USA 104(49):19458-19463.
21. Sun Y, et al. (2006) B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 53(2):143-151.
22. Dai W, Shen G, Qiu J, Zhao X, Gao Q (2014) Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis. Oncol Rep 32(5):2086-2092.
23. Arigami T, et al. (2011) B7-H3 expression in gastric cancer: A novel molecular blood marker for detecting circulating tumor cells. Cancer Sci 102(5):1019-1024.
24. Yamato I, et al. (2009) Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer 101(10):1709-1716.
25. Zang X, et al. (2010) Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Mod Pathol 23(8):1104-1112.
26. Sun J, et al. (2010) Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother 59(8):1163-1171.
27. Boorjian SA, et al. (2008) T-cell coregulatory molecule expression in urothelial cell carcinoma: Clinicopathologic correlations and association with survival. Clin Cancer Res 14(15):4800-4808.
28. Crispen PL, et al. (2008) Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res 14(16):5150-5157.
29. Katayama A, et al. (2011) Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis. Int J Oncol 38(5):1219-1226.
30. Hsu TL, et al. (2007) Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells. Proc Natl Acad Sci USA 104(8):2614-2619.
31. Smulow JB, Glickman I (1966) An epithelial-like cell line in continuous culture from normal adult human gingiva. Proc Soc Exp Biol Med 121(4):1294-1296.
32. Hanson SR, et al. (2007) Tailored glycoproteomics and glycan site mapping using saccharide-selective bioorthogonal probes. J Am Chem Soc 129(23):7266-7267.
33. Chen R, et al. (2009) Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res 8(2):651-661.
34. Hsu TL, et al. (2013) The surface carbohydrates of the Echinococcus granulosus larva interact selectively with the rodent Kupffer cell receptor. Mol Biochem Parasitol 192(1-2):55-59.
35. Chen PC, et al. (2014) Role of N-linked glycans in the interactions of recombinant HCV envelope glycoproteins with cellular receptors. ACS Chem Biol 9(7):1437-1443.
36. Hsu TL, et al. (2009) Profiling carbohydrate-receptor interaction with recombinant innate immunity receptor-Fc fusion proteins. J Biol Chem 284(50):34479-34489.
37. Arigami T, et al. (2010) B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis. Ann Surg 252(6):1044-1051.
38. Loos M, et al. (2009) Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer. BMC Cancer 9:463.
39. Wu CP, et al. (2006) Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 12(3):457-459.
40. Seaman S, et al. (2007) Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11(6):539-554.
41. Gao S, et al. (2004) Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer 109(2):230-237.
42. Campi C, et al. (2007) Secretor status and ABH antigens expression in patients with oral lesions. Med Oral Patol Oral Cir Bucal 12(6):E431-E434.
43. Ravn V, Dabelsteen E (2000) Tissue distribution of histo-blood group antigens. APMIS 108(1):1-28.
44. Castriconi R, et al. (2004) Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc Natl Acad Sci USA 101(34):12640-12645.
45. García-Vallejo JJ, van Kooyk Y (2009) Endogenous ligands for C-type lectin receptors: The true regulators of immune homeostasis. Immunol Rev 230(1):22-37.